Moyad Jamal Shahwan
Moyad Jamal Shahwan publishes mostly in Molecular Biology, Physiology and Computational Theory and Mathematics, on topics such as Computational Drug Discovery Methods, Pharmaceutical Practices and Patient Outcomes and Alzheimer's disease research and treatments.
- World rank
- #241,096 of 7,710,434 ranked researchers
- Rank in United Arab Emirates
- #282 of 6,273
- Works
- 371
- Citations
- 33k
- Citations per work
- 88.0
What does Moyad Jamal Shahwan research?
Moyad Jamal Shahwan's work is mostly in Medicine (13%), Biochemistry, Genetics and Molecular Biology (10%), Computer Science (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else26972.5%
- Health Sciences5013.4%
- Medicine5013.4%
- Life Sciences3910.4%
- Physical Sciences143.7%
- Computer Science143.7%
- 1Molecular Biology10% of their works
- 2Physiology4% of their works
- 3Computational Theory and Mathematics4% of their works
- 4Epidemiology3% of their works
- 5Public Health, Environmental and Occupational Health3% of their works
- 6Endocrinology, Diabetes and Metabolism3% of their works
Research topics
- Computational Drug Discovery Methods
- Pharmaceutical Practices and Patient Outcomes
- Alzheimer's disease research and treatments
- Antibiotic Use and Resistance
- Cholinesterase and Neurodegenerative Diseases
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer-related molecular mechanisms research
- Vitamin D Research Studies
Which keywords describe Moyad Jamal Shahwan's research?
The keywords of their largest research topics: Molecular Docking, Virtual Screening, Amyloid Hypothesis, Cardiovascular Disease, Inappropriate Medication Use, Polypharmacy, Tau Pathology and Antibiotic Resistance.
- Vitamin D
- Long Noncoding RNAs
- Metabolic Syndrome
- Cholinesterase Inhibitors
- Cancer
- Antibiotic Resistance
- Polypharmacy
- Cardiovascular Disease
- Virtual Screening
- Molecular Docking
- Amyloid Hypothesis
- Inappropriate Medication Use
- Tau Pathology
- Antimicrobial Stewardship
- Acetylcholinesterase
- Diabetes
- Deficiency
- RNA Regulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Molecular Docking381 topic
- Virtual Screening381 topic
- Amyloid Hypothesis191 topic
- Cardiovascular Disease192 topics
- Inappropriate Medication Use191 topic
- Polypharmacy191 topic
- Tau Pathology191 topic
- Antibiotic Resistance181 topic
- Antimicrobial Stewardship181 topic
- Cancer182 topics
- Acetylcholinesterase131 topic
- Cholinesterase Inhibitors131 topic
- Diabetes101 topic
- Metabolic Syndrome101 topic
- Deficiency91 topic
- Long Noncoding RNAs91 topic
- RNA Regulation91 topic
- Vitamin D91 topic
Where does Moyad Jamal Shahwan work?
Moyad Jamal Shahwan's main affiliation in the publication record is Ajman University, United Arab Emirates.
How many publications and citations does Moyad Jamal Shahwan have?
OpenAlex counts 371 works and 32,643 citations for Moyad Jamal Shahwan, an h-index of 48, ranking #241,096 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Moyad Jamal Shahwan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.